{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:52:57Z","timestamp":1761630777221},"reference-count":42,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.7201","type":"journal-article","created":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T17:25:09Z","timestamp":1485883509000},"page":"347-351","source":"Crossref","is-referenced-by-count":5,"title":["Fulminant Laryngeal-tracheobronchial-pulmonary Aspergillosis: A Rare and Fatal Complication in Allogeneic Hematopoietic Stem Cell Transplantation Recipients"],"prefix":"10.2169","volume":"56","author":[{"given":"Tao","family":"Tao","sequence":"first","affiliation":[{"name":"Department of Hematology, the Xinghai Hospital of Suzhou Industrial Park, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiology, the Xinghai Hospital of Suzhou Industrial Park, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Li","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Hematology, the First Affiliated Hospital of Soochow University, China"},{"name":"Hematopoietic Transplant Institute, Soochow University, China"},{"name":"Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-Pei","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hematology, the First Affiliated Hospital of Soochow University, China"},{"name":"Hematopoietic Transplant Institute, Soochow University, China"},{"name":"Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, the First Affiliated Hospital of Soochow University, China"},{"name":"Hematopoietic Transplant Institute, Soochow University, China"},{"name":"Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","first-page":"1068","volume":"91","author":"L Pagano","year":"2006","unstructured":"1. Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 91: 1068-1075, 2006.","journal-title":"Haematologica","ISSN":"http:\/\/id.crossref.org\/issn\/0390-6078","issn-type":"print"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sun Y, Xu L, Liu D, et al. Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation. Clin Microbiol Infect 19: 1029-1034, 2013.","DOI":"10.1111\/1469-0691.12120"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sun YQ, Xu LP, Liu DH, et al. The incidence and risk factors of invasive fungal infection after haploidentical haematopoietic stem cell transplantation without in vitro T-cell depletion. Clin Microbiol Infect 18: 997-1003, 2012.","DOI":"10.1111\/j.1469-0691.2011.03697.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Segal BH. Aspergillosis. N Engl J Med 360: 1870-1884, 2009.","DOI":"10.1056\/NEJMra0808853"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Temime J, Mallat J, Van Grunderbeeck N, Gimenez S, Lemyze M. Fulminant invasive tracheobronchial aspergillosis. Am J Respir Crit Care Med 191: 848-849, 2015.","DOI":"10.1164\/rccm.201501-0035IM"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Williams MS, Ali N, Nonaka D, Bloor AJ, Somervaille TC. Fatal invasive aspergillosis of the larynx. Eur J Haematol 90: 354, 2013.","DOI":"10.1111\/ejh.12054"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. He H, Jiang S, Zhang L, et al. <i>Aspergillus<\/i> tracheobronchitis in critically ill patients with chronic obstructive pulmonary diseases. Mycoses 57: 473-482, 2014.","DOI":"10.1111\/myc.12185"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hartemink KJ, Paul MA, Spijkstra JJ, Girbes AR, Polderman KH. Immunoparalysis as a cause for invasive aspergillosis? Intensive Care Med 29: 2068-2071, 2003.","DOI":"10.1007\/s00134-003-1778-z"},{"key":"9","unstructured":"9. Gangopadhyay M, Majumdar K, Bandyopadhyay A, Ghosh A. Invasive primary aspergillosis of the larynx presenting as hoarseness and a chronic nonhealing laryngeal ulcer in an immunocompetent host: a rare entity. Ear Nose Throat J 93: 265-268, 2014."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Liu DH, Xu LP, Zhang XH, et al. Substitution of cyclophosphamide in the modified BuCy regimen with fludarabine is associated with increased incidence of severe pneumonia: a rospective, randomized study. Int J Hematol 98: 708-715, 2013.","DOI":"10.1007\/s12185-013-1460-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Storb R, Antin JH, Cutler C. Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease? Biol Blood Marrow Transplant 16: S18-S27, 2010.","DOI":"10.1016\/j.bbmt.2009.10.016"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kramer MR, Denning DW, Marshall SE, et al. Ulcerative tracheobronchitis after lung transplantation: a new form of invasive aspergillosis. Am Rev Respir Dis 144: 552-556, 1991.","DOI":"10.1164\/ajrccm\/144.3_Pt_1.552"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kurosawa M, Yonezumi M, Hashino S, et al. Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol 96: 748-757, 2012.","DOI":"10.1007\/s12185-012-1210-y"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hu R, Jiang XY, Wu Y. Risk factors for invasive pulmonary fungal infection in patients with hematological malignancies not receiving hematopoietic stem cell transplant. Neoplasma 59: 669-675, 2012.","DOI":"10.4149\/neo_2012_085"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zhang P, Jiang EL, Yang DL, et al. Risk factors and prognosis of invasive fungal infection in allogeneic stem cell transplantation recipients: a single-institution experience. Transpl Infect Dis 12: 316-321, 2010.","DOI":"10.1111\/j.1399-3062.2010.00497.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Srinivasan A, Wang C, Srivastava DK, et al. Timeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 19: 94-101, 2013.","DOI":"10.1016\/j.bbmt.2012.08.012"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Fern\u00e1ndez-Ruiz M, Silva JT, San-Juan R, et al. <i>Aspergillus<\/i> tracheobronchitis: report of 8 cases and review of the literature. Medicine (Baltimore) 91: 261-273, 2012.","DOI":"10.1097\/MD.0b013e31826c2ccf"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ohashi T, Mizuta K, Kuze B, Aoki M, Ito Y. Invasive epiglottic aspergillosis: a case report and literature review. Auris Nasus Larynx 42: 501-504, 2015.","DOI":"10.1016\/j.anl.2015.05.001"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Machida U, Kami M, Kanda Y, et al. <i>Aspergillus tracheobronchitis<\/i> after allogeneic bone marrow transplantation. Bone Marrow Transplant 24: 1145-1149, 1999.","DOI":"10.1038\/sj.bmt.1702030"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer\/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC\/MSG) consensus group. Clin Infect Dis Off Publ Infect Dis Soc Am 46: 1813-1821, 2008.","DOI":"10.1086\/588660"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Guinea J, Bouza E. Current challenges in the microbiological diagnosis of invasive aspergillosis. Mycopathologia 178: 403-416, 2014.","DOI":"10.1007\/s11046-014-9763-3"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafaildis PI, Falagas ME. \u03b2-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 52: 750-770, 2011.","DOI":"10.1093\/cid\/ciq206"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Nishiyama KH, Falc\u00e3o Ede A, Kay FU, Teles GB, Bernardi Fdel C, Funari MB. Acute tracheobronchitis caused by <i>Aspergillus<\/i>: case report and imaging findings. Radiol Bras 47: 317-319, 2014.","DOI":"10.1590\/0100-3984.2013.1854"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Wu N, Huang Y, Li Q, Bai C, Huang HD, Yao XP. Isolated invasive <i>Aspergillus<\/i> tracheobronchitis: a clinical study of 19 cases. Clin Microbiol Infect 16: 689-695, 2010.","DOI":"10.1111\/j.1469-0691.2009.02923.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Krenke R, Grabczak EM. Tracheobronchial manifestations of <i>Aspergillus<\/i> infections. ScientificWorldJournal 11: 2310-2329, 2011.","DOI":"10.1100\/2011\/865239"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tasci S, Glasmacher A, Lentini S, et al. Pseudomembranous and obstructive <i>Aspergillus<\/i> tracheobronchitis - optimal diagnostic strategy and outcome. Mycoses 49: 37-42, 2006.","DOI":"10.1111\/j.1439-0507.2005.01180.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Salmeron G, Porcher R, Bergeron A, et al. Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis. Haematologica 97: 1357-1363, 2012.","DOI":"10.3324\/haematol.2011.058255"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Schelenz S, Barnes RA, Barton RC, et al. British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases. Lancet Infect Dis 15: 461-474, 2015.","DOI":"10.1016\/S1473-3099(15)70006-X"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kim SW, Rhee CK, Kang HS, et al. Diagnostic value of bronchoscopy in patients with hematologic malignancy and pulmonary infiltrates. Ann Hematol 94: 153-159, 2015.","DOI":"10.1007\/s00277-014-2172-3"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Chellapandian D, Lehrnbecher T, Phillips B, et al. Bronchoalveolar lavage and lung biopsy in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review and meta-analysis. J Clin Oncol 33: 501-509, 2015.","DOI":"10.1200\/JCO.2014.58.0480"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Grosu HB, Bashoura L, Ost D, Ordonez NG, Faiz SA. Critical airway obstruction due to pseudomembranous <i>Aspergillus<\/i> tracheitis. Am J Respir Crit Care Med 190: 65-66, 2014.","DOI":"10.1164\/rccm.201405-0895IM"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Stather DR, Tremblay A, MacEachern P, et al. Bronchoscopic removal of a large intracavitary pulmonary aspergilloma. Chest 143: 238-241, 2013.","DOI":"10.1378\/chest.12-0400"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46: 327-360, 2008.","DOI":"10.1086\/525258"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347: 408-415, 2002.","DOI":"10.1056\/NEJMoa020191"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Enoch DA, Idris SF, Aliyu SH, Micallef C, Sule O, Karas JA. Micafungin for the treatment of invasive aspergillosis. J Infect 68: 507-526, 2014.","DOI":"10.1016\/j.jinf.2014.01.007"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 39: 743-746, 2004.","DOI":"10.1086\/423274"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Wade RL, Chaudhari P, Natoli JL, Taylor RJ, Nathanson BH, Horn DL. Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex. Diagn Microbiol Infect Dis 76: 361-367, 2013.","DOI":"10.1016\/j.diagmicrobio.2013.04.001"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Kirkpatrick WR, Perea S, Coco BJ, Patterson TF. Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis. Antimicrob Agents Chemother 46: 2564-2568, 2002.","DOI":"10.1128\/AAC.46.8.2564-2568.2002"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Nagasaki Y, Eriguchi Y, Uchida Y, et al. Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model. J Antimicrob Chemother 64: 379-382, 2009.","DOI":"10.1093\/jac\/dkp175"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Panackal AA, Parisini E, Proschan M. Salvage combination antifungal therapy for acute invasive aspergillosis may improve outcomes: a systematic review and meta-analysis. Int J Infect Dis 28: 80-94, 2014.","DOI":"10.1016\/j.ijid.2014.07.007"},{"key":"41","unstructured":"41. Marr KA, Schlamm H, Rottinghaus ST, et al. A randomised, double-blind study of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis. Clin Microbiol Infect 18: 713, 2012."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Raad II, Hanna HA, Boktour M, et al. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Leukemia 22: 496-503, 2008.","DOI":"10.1038\/sj.leu.2405065"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/3\/56_56.7201\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T05:28:00Z","timestamp":1498368480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/3\/56_56.7201\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.7201","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}